Education
About Us
Working with TipRanks
Follow Us
Akums Drugs and Pharmaceuticals Limited (IN:AKUMS)
:AKUMS
AKUMS Stock Chart & Stats
₹420.10
₹13.30(2.17%)
At close: 4:00 PM EST
₹420.10
₹13.30(2.17%)
Day’s Range― - ―
52-Week Range₹407.40 - ₹635.25
Previous CloseN/A
Volume56.90K
Average Volume (3M)11.50K
Market Cap
₹70.30B
Enterprise Value₹67.95B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)21.6
Beta1.54
Next Earnings
Feb 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.60
Shares Outstanding157,393,980
10 Day Avg. Volume12,021
30 Day Avg. Volume11,497
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Akums Drugs and Pharmaceuticals Limited News
AKUMS FAQ
What was Akums Drugs and Pharmaceuticals Limited’s price range in the past 12 months?
Akums Drugs and Pharmaceuticals Limited lowest stock price was ₹407.40 and its highest was ₹635.25 in the past 12 months.
What is Akums Drugs and Pharmaceuticals Limited’s market cap?
Akums Drugs and Pharmaceuticals Limited’s market cap is ₹70.30B.
When is Akums Drugs and Pharmaceuticals Limited’s upcoming earnings report date?
Akums Drugs and Pharmaceuticals Limited’s upcoming earnings report date is Feb 05, 2026 which is in 24 days.
How were Akums Drugs and Pharmaceuticals Limited’s earnings last quarter?
Akums Drugs and Pharmaceuticals Limited released its earnings results on Nov 13, 2025. The company reported ₹2.6 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.6.
Is Akums Drugs and Pharmaceuticals Limited overvalued?
According to Wall Street analysts Akums Drugs and Pharmaceuticals Limited’s price is currently Overvalued.
Does Akums Drugs and Pharmaceuticals Limited pay dividends?
Akums Drugs and Pharmaceuticals Limited does not currently pay dividends.
What is Akums Drugs and Pharmaceuticals Limited’s EPS estimate?
Akums Drugs and Pharmaceuticals Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Akums Drugs and Pharmaceuticals Limited have?
Akums Drugs and Pharmaceuticals Limited has 157,393,980 shares outstanding.
What happened to Akums Drugs and Pharmaceuticals Limited’s price movement after its last earnings report?
Akums Drugs and Pharmaceuticals Limited reported an EPS of ₹2.6 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.542%.
Which hedge fund is a major shareholder of Akums Drugs and Pharmaceuticals Limited?
Currently, no hedge funds are holding shares in IN:AKUMS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Akums Drugs and Pharmaceuticals Limited
Akums Drugs and Pharmaceuticals Limited (AKUMS) is a leading Indian pharmaceutical manufacturer and exporter, specializing in the production of a wide range of pharmaceutical formulations and active pharmaceutical ingredients (APIs). Established in 2004, the company primarily operates in the sectors of prescription medicines, over-the-counter (OTC) products, and nutraceuticals. AKUMS is known for its commitment to quality and innovation, offering a diverse portfolio that includes formulations across various therapeutic segments such as cardiology, gynecology, and dermatology.
Technical Analysis
Bafna Pharmaceuticals Limited
―
Bal Pharma Limited
―
Indraprastha Medical Corporation Limited
―
Kopran Limited
―
Wanbury Limited
―